Table 1. Absorbance vs. Incubation Time 0.46 ... - Clinical Chemistry

3 downloads 0 Views 450KB Size Report
and statistically tested to obtain linear .... CPK-MB. (1) indicate that “electro- phoretic techniques used were not sensitive ... and Varat's report of CPK-MB in con-.
much more strongly (257 = 21500) than in neutral or acidic medisorb

um

(#{128}255 = 740),

a change

that

Table 1. Absorbance vs. Incubation Time

can be

Time at 37#{176}C, mm

produced repeatedly with a sample. 45

60

75

90

Creatinine-free serum

0.00

0.00

0.00

0.00

Creatinine-free serum with added creatinine, 50, 100 and 150 mg/liter

0.46 0.94

0.50

1.00

0.50 1.00

1.43

1.50

1.50

0.50 1.00 1.50

Normal serum

0.09

0.10

0.10

0.10

Sample

A quantitative modification of the TLC technique is also possible, but it requires equipment that costs about as much as that for GLC or RIA. With the chromatogram spectrophotometer (Zeiss, Oberkochen, F. R. Germany) a 0.5-gig sample of barbital can be detected. This same instrument was used in an earlier work to assess imipramine and desipramine in human blood plasma (2), and recently has been modified and statistically tested

Uremic serum

1.12

1.20

1.20

1.20

Aqueous creatinine, 50, 100 and 150

0.50 1.00

0.50 1.00 1.50

0.50

0.50 1.00

to obtain linear relationship between substance amount and instrument response (3). Several years of experience with TLC scanners in the analysis of steroids, pharmaceuticals, and drugs in biological samples suggest that these instruments deserve the clinical chemists’ attention. If properly used, they offer great sensitivity and reliability. Because detection is a nondestructive process, the samples are available for further studies after the measurement. For confirmatory reasons an appropriate reagent may be used for visualization, or subsequent GLC and RIA can be used, if the circumstances require it.

References 1. Roerig, D. L., Lewand, D. L., Mueller, M. A., and Wang, I. H., Comparison of radioimmunoassay with thin-layer chromato-

graphic

and

gas-liquid

chromatographic

methods of barbiturate detection in human urine. Clin. Chem. 21, 672 (1975). 2. Nagy, A., and Treiber, L., Quantitative determination of imipramine and desipramine in human blood plasma by direct

densitometry

of thin-layer

J. Pharm. Pharmacol.

chromatograms.

25, 599

(1973).

3. Treiber, L. R., Standardisation of the direct spectrophotometric quantitative analysis of chromatograms. IV. A comparative study on the most common mathematical treatments of thin-layer densitometric problems. J. Chromatogr. 100, 123 (1974).

mg/liter

sorbance of the second reagent measured vs. the first determines the creatinine concentration of the sample. Chromogens do not interfere. In further studies of the Jaff#{233} reaction at pH 11.50, I find that the protein interference can be completely eliminated if the alkaline picrate reagent is added after heat coagulation of the serum sample. This permits estimation of “true” creatinine by the following procedure: Transfer 0.10 ml of serum to the bottom of a 100 X 15 mm tube. Place in a boiling water bath

for 3 mm, remove, cool, and add 0.75 ml of the alkaline picrate reagent buffered at 11.50 (1, 2). Keep the tube at 37 #{176}C for 60 mm, and measure the absorbance at 500 nm (10-mm pathlength cuvet) vs. 0.10 ml of water with 0.75 ml alkaline picrate reagent also incubated at 37 #{176}C. The validation and accuracy of this procedure are presented in Table 1. Creatinine-free serum does not react at all with the alkaline picrate reagent for as long as 90 mm. This was consistently observed for 100 different sera, some of which were lipemic, icteric, or hemolyzed (protein 4.5-7.8 g/dl) that had previously been dialyzed as mentioned elsewhere (1).

Creatinine-free Laszlo

R. Treiber

Improved DeterminatIon of “True” Creatinine in Serum or Plasma

termined

“true” serum creatby a simple spectrophotometric measurement by using two alkaline picrate reagents, buffered at pH 9.65 and 11.50. The mine

can

color

produced

2),

be determined

from

the

reaction

serum with the first reagent protein alone, whereas, with the second reagent protein and creatinine.

1848

CUNICAL

of

is due to

that produced is due to both Thus, the ab-

CHEMISTRY,

serum

with added cre-

atinine and serum from normal and uremic subjects, as well as aqueous creatinine solutions, give similar reaction. Complete extraction and full development of color are attained after 60 mm and remain stable as long as 90 mm. “True” creatinine can thus be de-

Dept. of Macromolecular Science Case Western Reserve University Cleveland, Ohio 44106

To the Editor: As reported (1,

1.50

with

a

single

reagent

and

without need for a blank. The procedure also has the advantage of being equally applicable to plasma and not exclusively to serum, as the initial one was because of the appearance of turbidity when plasma is reacted with alkaline picrate reagent buffered at 9.65. No difference was recorded between creatinine in serum and heparinized plasma for 50 subjects (6-170 mg/ liter). Absorbance was linear from 5 to

Vol. 21, No. 12. 1975

200

1.00 1.50

mg of creatinine

1.50

per liter, with a

coefficient of variation and percentage of recovery ranging between 0.5-1.5% and 98-101%, respectively. References 1. Yatzidis H., New method for direct determination of “true” creatinine. Clin. Chem. 20, 1131 (1974). 2. Correction. Clin. Chem. 21, 157 (1975). Hippocrates

Yatzidis

Nephrological Center Aretaieon University Hospital Athens 611, Greece

Creatine Klnase lsoenzyme MB and Heart Disease To the Editor: Mercer and Varat in their study of CPK-MB (1) indicate that “electrophoretic techniques used were not sensitive enough to detect the low MB activity in sera with normal or slightly above-normal total CK activity.” This statement needs to be clarified in light of other studies (2). We have reported 100%

sensitivity

of CPK-MB

for

myo-

cardial infarction in a series of 100 consecutive admissions to the CCU, using a fluorometric agarose electrophoretic system. Furthermore, we reported 3% of total activity as our cutoff for CPK-MB, which agrees very well with the above authors’ results. What is most interesting is Mercer and Varat’s report of CPK-MB in congestive heart failure, atrial fibrillation and cardiomyopathy. We similarly found and reported CPK-MB (above 3%)

in cases

of coronary

insufficiency,

angina, congestive heart failure and pulmonary embolism. Our assay permits detection of significant amounts of CPK-MB

in

the clinical

course,

still

within

infarct

normal

cases total limits.

while

early

in

CPK is Clearly,

electrophoretic separation in agarose followed by fluorometric detection meets the criteria of sensitivity and

specificity jremely

to be considered accurate

diagnostic

test

NORMAL

an ex(3).

References

K

60.

K

(23-43)

1. Mercer,D. W. and Varat,M. A.,Detection

of cardiac-specific

creatine

kinase

iso-

enzyme in serawith normal or slightly increased total creatine kinase activity. Clin. Chem. 21, 1088 (1975). 2. Galen,R. S.,Reiffel, J. A., Gambino, S. R., Diagnosis of acute myocardial infarction. J. Am. Med. Assoc. 232, 145 (1975).

3. Krieg, A. F., Gambino, S. R., and Galen, R. S.,Why are clinical laboratory tests performed? When are they valid? J. Am. Med. Assoc. 233, 76 (1975). Robert

S. Raymond Department

Columbia Medical

0

0

K, K,

(17-41) 40-

0

340 (24-4)

Presbyterian Center

New York, N. Y. 10032

To the Editor:

We find that abnormal blood samples give a different yield of porphyrin in the extraction procedure used in this method. Seven to nine extractions with acidified ether were necessary to completely extract the porphyrin, i.e., obtain zero or small negative porphyrin values in further extractions. We also observed that six extractions removed 82 to 90% of the porphyrin present in the blood sample. Accordingly, we decided to assay normal and abnormal samples by using the procedure as originally described, i.e., measuring the porphyrin present in the combined first two extractions with acidified ether, designated as EP2 in to

this report. We then did four further extractions in the same way. The porphyrin present in the combined third to sixth extractions is designated EP4. All assays were done with reagents belonging to single batches. We obtained data on EP2 and EP4 for 33 heparmnized blood samples divided into two groups: 12 normal adults (10 men and two women), and 21 anemic patients (10 women in the puerperium; three women and one man with iron-deficiency anemia; and seven patients with hypoplastic anemia, of whom two were males). The samples were assayed within 0.5 to 4 h after extraction and were kept refrig1850

J

DIAGNOsIs

A BC

Fig. 1. The percentage ratio EP2/(EP2 + EP4) for 12 normal individuals and 21 anemic patients In the latter, the mean and range of the hematocrit in the three subgroups made on the basis of

the ratio are shown in the right-hand column. Diagnoses In the anemic group: A, 10 women in the puerperium; B, 4 patIents with iron-deficiency anemia; C. 7 wIth hypoplastic anemia. Sex Is Indicated by (x) for females, and (.) for males

erated. The hematocrit was estimated in Wintrobe tubes centrifuged for 30 mm (2200 X g). Table 1 summarizes our results for the normal and anemic groups. The standard deviation corresponded well with the range in the normal group but not in the anemic one. Significant differences by the t-test between groups were present in the five variables shown in Table 1. Although the

differences

hematocrit and the EPs

in

are in agreement with other reports in the literature, the group difference (t = 3.94;p = 0.0002) in the ratio EP2/ (EP2 + EP4) is unexpected and prompts

this

into with

nor etiology

three an EP/

Letter.

of the anemia

with the differences

ratio in these Technical

20

for

to 49%), and five with a higher ratio (56 to 65%). As Figure 1 shows, neither correlated

Gambino

The WHO (1) has urged research on the possibilities of using the assay of erythrocytic protoporphyrin in the study of nutritional anemias and has recommended the simplified procedure described by Heller et al. (2), a method in which total porphyrins, not just protoporphyrin, is measured.

subdivided four patients

hematocrit

C

of Pathology

ratio

(EP2 + EP4) ratio comparable to normal, 12 with intermediate values (38

#{149}

0.

the

in the ratio; they can be

er variation K,

that

normal individuals is narrow (30 to 36%) in 10 of the 12 subjects, and a single value of 46%, seen in a normal woman with a hematocrit of 50%, fell outside the limits of mean ±2 SD. In contrast, the anemic group had a larggrossly subgroups:

50-i

S. Galen

Difference in ExtractabIlity of Porphyrins from Blood of Anemic Persons

1 shows

Figure

ANEMIC

three subgroups. reasons appear

in the unlikely

as causes for the variations in the ratio: reagents used throughout the study came from single batches, and the spectrophotometer (Hitachi, Model 139) was in excellent working condition. It was also established that increasing the time or modifying the conditions of stirring when extractants were added did not alter results. The acetone/ethyl acetate mixture and the HC1 were excluded as sources of error. Delay in the separation of the HC1 layer from the acidified ether was avoided because it introduces errors that are directly proportional to time elapsed before separation. The ratio EP2/(EP2 + EP4) can be considered a measure of recovery of intrinsic porphyrins present in erythrocytes when two extractions with

acidified

ether are done. As such, our

recoveries never reach the 84 to 94% seen with two extractions by Heller et al. (2), but it should be pointed out that these authors and others (3-5) have used added (extrinsic) protoporphyrin in their recovery testing, and that decreased recovery in the presence of erythrocytes has been observed even for extrinsic protoporphynfl (5). We conclude that blood from anemic patients does not always behave

Table 1. Results for Porphyrin in Blood of 12 Normal and 21 Anemic Individuals Variable

Group

%a

Normal

Hematocrit,

Anemic EP2,pg/literb

EP4, pg/literc

EP2

+

155

33

923

507

1093

Normal

466

+

EP4) x 100

33.4

Anemic

44.5

120-220

240-2080 210-390

540-2520

488

72

330-600

821

2018

Normal

44-59 17-43

55

311

Anemic

Range

3.68 7.51

Normal

Anemic

EP2/(EP2

SD

51.6 32.5

Anemic Normal

EP4, pg/liter

Mean

780-3450

5.04

25-46

11.05

23-65

a Higher values because of Mexico b EP2, erythrocytic C

EP4, erythrocytic

CLINICAL CHEMISTRY, Vol. 21, No. 12, 1975

porphyrin

City altitude, 7350 feet. in the first two extractions with

porphyrin

in four further

extractions

acidified

ether.

with acidified

ether.